ABUS Competitors & Alternatives
Compare Arbutus Biopharma Corp with similar stocks in the same industry
Biotechnology
ABUS
Main Stock$5.12
Tradestie Score
47
Market Cap
$879.90M
P/E Ratio
6.5
Revenue Growth
-0.9%
Analyst Upside
+7.6%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$11.21
|
$1.05B | 77.2 | 42 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.57
|
$1.01B | 115.0 | 47 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$4.76
|
$997.16M | - | 45 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.13
|
$996.55M | - | 41 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$90.60
|
$994.20M | - | 66 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$6.66
|
$993.46M | - | 45 | Compare |
|
IMNM
Immunome, Inc.
|
$24.67
|
$987.09M | - | 44 | Compare |
|
ANL
ANL
|
$15.21
|
$971.76M | - | 47 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.13
|
$951.83M | - | 50 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
More ABUS Analysis
Data updated: Sep 14, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry